Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

FDA grants orphan drug status to Keryx's perifosine for neuroblastoma

July 16, 2010

Vertex scientists present new ATR kinase inhibitors

July 16, 2010

ChemGenex to submit new NDA for Omapro as third-line CML therapy

July 15, 2010

Peregrine begins second phase IIb trial of bavituximab in NSCLC

July 15, 2010

Linifanib/mFOLFOX6 combination shows promise in metastatic colorectal cancer

July 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...